Shirai Yurie, Nagao Michinobu, Inoue Akihiro, Yamamoto Atsushi, Kaneko Koichiro, Sakai Akiko, Suzuki Atsushi, Yamaguchi Junichi, Sakai Shuji
Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, Japan.
Ann Nucl Med. 2025 Jun 14. doi: 10.1007/s12149-025-02070-3.
F-Fludeoxyglucose (FDG) PET/CT is an effective tool for detecting active cardiac sarcoidosis (CS), but often has difficulty distinguishing CS lesions from physiological myocardial accumulation. We investigated the potential of the glucose metabolic rate (MR, mg/min/100mL) from four-dimensional FDG PET/CT in distinguishing between CS and physiological accumulation. Additionally, we compared CS delineation between MR and standardized uptake value (SUV).
A total of 192 individuals with CS or suspected CS who underwent four-dimensional FDG PET/CT after 18 h fasting was enrolled. Ultimately, 45 individuals with CS and 14 patients with physiological accumulation, with SUV ≥ 2.7 accumulation in the left ventricular myocardium, were analyzed. The SUV, MR, and the ratio of MR to SUV (MR/SUV) were calculated for each lesion with SUV ≥ 2.7 using data acquired between 30 and 50 min on four-dimensional FDG PET/CT. In the CS group, lesion-to-normal myocardium contrast ratios on MR and SUV images were compared.
A total of 127 lesions from 45 individuals with CS and 43 physiological accumulations from 14 individuals were analyzed. The SUV, MR and MR/SUV for CS lesions were significantly lower than those for physiological accumulations (SUV, 4.26±1.35 vs. 6.06±3.28; MR, 1.91 ± 1.02 vs. 3.78 ± 2.11; MR/SUV, 0.43 ± 0.14 vs. 0.63 ± 0.14; p < 0.0001). Receiver operating characteristic analysis revealed that the ability to discriminate CS lesions from physiological accumulations yielded areas under the curves of 0.656, 0.808, and 0.849; sensitivities of 68, 76, and 73%; and specificities of 61, 72, and 84%, for SUV 4.525, MR 2.41, and MR/SUV 0.518. In the CS group, the contrast ratio of lesions was significantly greater on MR images than on SUV images (6.36 ± 6.17 vs. 2.54 ± 1.03, p < 0.0001).
MR from four-dimensional FDG PET/CT is a useful quantitative measure to distinguish CS lesions from physiological accumulation and enables better visualization of CS lesion contrast than SUV.
氟脱氧葡萄糖(FDG)PET/CT是检测活动性心脏结节病(CS)的有效工具,但在区分CS病变与生理性心肌摄取方面常常存在困难。我们研究了四维FDG PET/CT的葡萄糖代谢率(MR,mg/min/100mL)在区分CS与生理性摄取方面的潜力。此外,我们比较了MR和标准化摄取值(SUV)在CS病变勾画方面的差异。
共纳入192例CS患者或疑似CS患者,这些患者在禁食18小时后接受了四维FDG PET/CT检查。最终,分析了45例CS患者和14例生理性摄取患者,其左心室心肌SUV≥2.7。使用四维FDG PET/CT在30至50分钟之间获取的数据,计算每个SUV≥2.7的病变的SUV、MR以及MR与SUV的比值(MR/SUV)。在CS组中,比较了MR和SUV图像上病变与正常心肌的对比率。
共分析了45例CS患者的127个病变和14例患者的43个生理性摄取。CS病变的SUV、MR和MR/SUV显著低于生理性摄取(SUV,4.26±1.35对6.06±3.28;MR,1.91±1.02对3.78±2.11;MR/SUV,0.43±0.14对0.63±0.14;p<0.0001)。受试者操作特征分析显示,区分CS病变与生理性摄取的能力在SUV为4.525、MR为2.41、MR/SUV为0.518时,曲线下面积分别为0.656、0.808和0.849;敏感度分别为68%、76%和73%;特异度分别为61%、72%和84%。在CS组中,MR图像上病变的对比率显著高于SUV图像(6.36±6.17对2.54±1.03,p<0.0001)。
四维FDG PET/CT的MR是区分CS病变与生理性摄取的有用定量指标,与SUV相比,能更好地显示CS病变的对比。